BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24373819)

  • 1. Central nervous system lymphoma associated with natalizumab.
    Na A; Hall N; Kavar B; King J
    J Clin Neurosci; 2014 Jun; 21(6):1068-70. PubMed ID: 24373819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natalizumab-associated central nervous system lymphoma?--another patient.
    Matzke M; Schreiber S; Elolf E; Metz I; Mawrin C; Heinze HJ; Sailer M
    Mult Scler; 2012 Nov; 18(11):1653-4. PubMed ID: 22383229
    [No Abstract]   [Full Text] [Related]  

  • 3. Natalizumab, multiple sclerosis, and primary central nervous system lymphoma: enigma, wrapped in mystery, enclosed in conundrum.
    Ransohoff RM
    Ann Neurol; 2009 Sep; 66(3):259-61. PubMed ID: 19798722
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary central nervous system lymphoma in a patient treated with natalizumab.
    Schweikert A; Kremer M; Ringel F; Liebig T; Duyster J; Stüve O; Hemmer B; Berthele A
    Ann Neurol; 2009 Sep; 66(3):403-6. PubMed ID: 19798640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natalizumab: a double-edged sword?
    DeAngelis LM
    Ann Neurol; 2009 Sep; 66(3):262-3. PubMed ID: 19798644
    [No Abstract]   [Full Text] [Related]  

  • 6. Natalizumab-Associated Primary Central Nervous System Lymphoma.
    Nixon M; Menger RP; Kalakoti P; Thakur JD; Dossani RH; Sharma K; Nanda A; Guthikonda B
    World Neurosurg; 2018 Jan; 109():152-159. PubMed ID: 28962961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natalizumab and central nervous system lymphoma: no clear association.
    Bozic C; LaGuette J; Panzara MA; Sandrock AW
    Ann Neurol; 2009 Sep; 66(3):261-2. PubMed ID: 19798645
    [No Abstract]   [Full Text] [Related]  

  • 8. A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
    Chen H; Dong H
    Neurosciences (Riyadh); 2015 Oct; 20(4):380-4. PubMed ID: 26492120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary lymphoma of the central nervous system--a diagnostic challenge.
    Deckert M; Brunn A; Montesinos-Rongen M; Terreni MR; Ponzoni M
    Hematol Oncol; 2014 Jun; 32(2):57-67. PubMed ID: 23949943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Magnetic resonance features of primary central nervous system lymphoma in the immunocompetent patient: a pictorial essay.
    Yap KK; Sutherland T; Liew E; Tartaglia CJ; Pang M; Trost N
    J Med Imaging Radiat Oncol; 2012 Apr; 56(2):179-86. PubMed ID: 22498191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and diagnosis of primary central nervous system lymphoma.
    Fitzsimmons A; Upchurch K; Batchelor T
    Hematol Oncol Clin North Am; 2005 Aug; 19(4):689-703, vii. PubMed ID: 16083830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal injection of anti-VEGF and diagnosis of primary intraocular central nervous system lymphoma.
    Gambrelle J; Missotten G; Delhoum S; Desjardins L
    J Fr Ophtalmol; 2013 May; 36(5):431-4. PubMed ID: 23306179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary lymphoma of the central nervous system: 20 years' experience in a referral hospital].
    Calderón-Garcidueñas AL; Pacheco-Calleros J; Castelán-Maldonado E; Nocedal-Rustrián FC
    Rev Neurol; 2008 Jan 16-31; 46(2):84-8. PubMed ID: 18247279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Another complication of natalizumab treatment? Taking the challenge.
    Goebels N; Kappos L
    Ann Neurol; 2009 Sep; 66(3):264-6. PubMed ID: 19798646
    [No Abstract]   [Full Text] [Related]  

  • 15. Imaging of primary central nervous system lymphoma.
    Tang YZ; Booth TC; Bhogal P; Malhotra A; Wilhelm T
    Clin Radiol; 2011 Aug; 66(8):768-77. PubMed ID: 21513925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary central nervous system lymphoma.
    Abrey LE
    Curr Opin Neurol; 2009 Dec; 22(6):675-80. PubMed ID: 19741527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Primary central nervous system lymphoma and Creutzfeldt-Jakob disease].
    Pérez-Paredes MG; Tola-Arribas MA; Abad-Manteca L; Alonso-Santor JE
    Rev Neurol; 2004 Oct 1-15; 39(7):695. PubMed ID: 15490361
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary central nervous system lymphomas (PCNSL): MRI response criteria revised.
    Küker W; Nägele T; Thiel E; Weller M; Herrlinger U
    Neurology; 2005 Oct; 65(7):1129-31. PubMed ID: 16217075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary central nervous system lymphoma: an update.
    Soussain C; Hoang-Xuan K
    Curr Opin Oncol; 2009 Nov; 21(6):550-8. PubMed ID: 19684518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from fatal progressive multifocal leukoencephalopathy in a patient with multiple sclerosis treated with natalizumab.
    Boster AL; Nicholas JA; Topalli I; Kisanuki YY; Pei W; Morgan-Followell B; Kirsch CF; Racke MK; Pitt D
    JAMA Neurol; 2013 Mar; 70(3):398-402. PubMed ID: 23338729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.